The 'responsive and pragmatic' team at DLA Piper leverages the firm's international network of offices to act for global pharma companies in a range of matters. Marco de Morpurgo divides his time between the Rome and Brussels offices, and is well versed in assisting with market access issues, advertising matters and product classification cases; he co-heads the practice with Joost Haans. Jean-Christophe Top joined the team in January 2024.
Testimonials
Collated independently by Legal 500 research team.
‘The DLA team is responsive and pragmatic. Because of their global reach, they are able to act as a trusted partner for a wide range of matters in various jurisdictions. ’
‘Kristof De Vulder is very approachable, able to place himself in the client's position and provide valuable and actionable advice.’
Key clients
- Acadia Pharmaceuticals
- Eqology
- Guerbet
- Intra-Cellular Therapies
- IVC Evidensia
- NeuroTrauma Sciences
- NewLeaf
- Nipro
- Owkin
- Phuse
- Pierre Fabre
- TAE Life Sciences
- The Akkermansia Company
- Trace Sensing
- Unilabs
- WuXi Apptec
- AbbVie
- Amgen
- argenx
- AstraZeneca
- Bristol Myers Squibb
- Cegeka
- Gilead
- GlaxoSmithKline
- Incyte
- Ipsen
- JT
- Medica Group
- Medtronic
- Mozarc
- Nexuzhealth
- Novartis
- ResMed
- Sanofi
- Sarepta Therapeutics
- Stryker
- Syneos Health
- Takeda
- UCB
Work highlights
- Assisting Nipro with a broad range of matters, including research, distribution and manufacturing contracts, compliance issues and packaging issues.
- Advising Acadia Pharmaceutical on its entrance into the European market.
Practice head
The lawyer(s) leading their teams.
Marco de Morpurgo, Joost Haans